Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12968)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2019 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cerrito L, Annicchiarico BE, Iezzi R, Gasbarrini A, Pompili M, Ponziani FR. Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers. World J Gastroenterol 2019; 25(31): 4360-4382 [PMID: 31496618 DOI: 10.3748/wjg.v25.i31.4360] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i31/4360.htm |
| Number | Citing Articles |
| 1 |
Raffaele Borriello, Lucia Cerrito, Antonio Gasbarrini, Francesca Romana Ponziani. Pharmacokinetic considerations for angiogenesis inhibitors used to treat hepatocellular carcinoma: an overview. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(11): 785 doi: 10.1080/17425255.2023.2272598
|
| 2 |
Shivani Handa, Kamesh Gupta, Michelle Sterpi, Ahmad Khan, Abhinav Hoskote, Anup Kasi. Trends and In-Hospital Outcomes of Splanchnic Vein Thrombosis Associated with Gastrointestinal Malignancies: A Nationwide Analysis. Gastrointestinal Tumors 2021; 8(2): 71 doi: 10.1159/000513368
|
| 3 |
Jinghua Li, Daoming Zhu, Weijie Ma, Yang Yang, Ganggang Wang, Xiaoling Wu, Kunlei Wang, Yiran Chen, Fubing Wang, Wei Liu, Yufeng Yuan. Rapid synthesis of a Bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma. Nanoscale 2020; 12(32): 17064 doi: 10.1039/D0NR03907A
|
| 4 |
_ _, Oszkár Hahn, Attila Szijártó, Damján Pekli, András Fülöp, Bálint Kokas, Dávid Bárdos, Csilla András, Péter Bartek, István Battyáni, János Bezsilla, György Bodoky, Attila Bursics, Magdolna Dank, Zsófia Dankovics, Ákos Deák Pál, Kristóf Dede, Gyula Demeter, Attila Doros, Ibolyka Dudás, Zsófia Egyed, Róbert Farkas, Zsuzsanna Gerlei, Tamás Györke, Krisztina Hagymási, Oszkár Hahn, Erika Hitre, József Hőhn, Viktor Jancsik, Zsolt Káposztás, István Király, András Kiss, László Kóbori, Péter Kupcsulik, Gábor Lakatos, István Lázár, Tamás Lóderer, Endre Nagy, Attila Oláh, Péter Pajor, András Papp, Gabriella Pár, Mihály Patyánik, Damján Pekli, Ágota Petrányi, András Petri, László Piros, János Schuller, László Sikorszki, József Szabó, Eszter Székely, Attila Szijártó, Andrea Szombati, László Torday, Judit Tóth, Lajos Barna Tóth, Edit Dósa, László Harsányi, Zsolt Horváth, Gábor István, László Landherr, György Lázár, Gabriella Lengyel, József Lővey, László Mangel, Pál Maurovich Horváth, Balázs Nemes, András Palkó, Zsuzsa Schaff, Ferenc Szalay, Ákos Szűcs, András Vereczkei. A hepatocellularis carcinoma komplex kezelése.. Orvosi Hetilap 2022; 162(Supplement-2): 2 doi: 10.1556/650.2021.32431
|
| 5 |
Hong-Ming Tsai, Meng-Zhi Han, Yih-Jyh Lin, Ting-Tsung Chang, Chiung-Yu Chen, Pin-Nan Cheng, Chiao-Hsiung Chuang, I-Chin Wu, Po-Jun Chen, Jui-Wen Kang, Yen-Cheng Chiu, Hung-Chih Chiu, Shih-Chieh Chien, Hsin-Yu Kuo. Real-world outcome of immune checkpoint inhibitors for advanced hepatocellular carcinoma with macrovascular tumor thrombosis. Cancer Immunology, Immunotherapy 2021; 70(7): 1929 doi: 10.1007/s00262-020-02845-9
|
| 6 |
Jason Liu, Colton Ladbury, Arya Amini, Scott Glaser, Jonathan Kessler, Aram Lee, Yi-Jen Chen. Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis. Radiation Oncology Journal 2021; 39(2): 113 doi: 10.3857/roj.2021.00213
|
| 7 |
Cemalettin Aydin, Sezai Yilmaz. Is Macroscopic Portal Vein Tumor Thrombosis of HCC Really an Exclusion for Liver Transplantation?. Journal of Gastrointestinal Cancer 2020; 51(4): 1137 doi: 10.1007/s12029-020-00488-8
|
| 8 |
Jordan D. LeGout, Ryan E. Bailey, Candice W. Bolan, Andrew W. Bowman, Frank Chen, Joseph G. Cernigliaro, Lauren F. Alexander. Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion. RadioGraphics 2020; 40(7): 2098 doi: 10.1148/rg.2020200047
|
| 9 |
Yun Huang, Zeyu Zhang, Weijun Liao, Kuan Hu, Zhiming Wang. Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.650394
|
| 10 |
Piyush Goyal, Riad Salem, Samdeep K. Mouli. Role of interventional oncology in hepatocellular carcinoma: Future best practice beyond current guidelines. The British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20220379
|
| 11 |
Xuan-Hui Yan, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Yi-Fan Wu, Ming-Ming Meng, Ke Zhang, Li Jiang, Hui-Guo Ding, Yue-Ning Zhang, Yong-Ping Yang, Fu-Quan Liu. Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension. World Journal of Gastrointestinal Surgery 2022; 14(6): 567-579 doi: 10.4240/wjgs.v14.i6.567
|
| 12 |
Maria Pallozzi, Natalia Di Tommaso, Valeria Maccauro, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022; 14(19): 4631 doi: 10.3390/cancers14194631
|
| 13 |
玮 李. Progress in Surgical Treatment of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus. Advances in Clinical Medicine 2022; 12(11): 10566 doi: 10.12677/ACM.2022.12111521
|
| 14 |
Kylie E. Zane, Mina S. Makary. Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers 2021; 13(21): 5430 doi: 10.3390/cancers13215430
|
| 15 |
Runze Xie, Maojun You, Xin Wang, Shunda Du, Fu-Sheng Wang, Pengyuan Yang. Multimodal Studies in Hepatitis B Virus Associated Hepatocellular Carcinoma. Infectious Diseases & Immunity 2022; 2(3): 204 doi: 10.1097/ID9.0000000000000052
|
| 16 |
Li-Min Yang, Hong-Juan Wang, Shan-Lin Li, Guan-Hua Gan, Wen-Wen Deng, Yong-Sheng Chang, Lian-Feng Zhang. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors. World Journal of Gastroenterology 2024; 30(11): 1533-1544 doi: 10.3748/wjg.v30.i11.1533
|
| 17 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
| 18 |
Hao Sun, Bing Ma, Ning Sun, Han Bai, Xuejian Li, Chengshuo Zhang. Survival benefit of perioperative locoregional adjuvant treatment for hepatocellular carcinoma with portal vein tumor thrombosis: A systematic review and Bayesian network meta-analysis. Critical Reviews in Oncology/Hematology 2023; 189: 104083 doi: 10.1016/j.critrevonc.2023.104083
|
| 19 |
Xiaofan Feng, Tianyi Jiang, Chun Yang, Shujie Pang, Zhiwen Ding, Heping Hu, Hui Wang, Liwei Dong, Ning Yang. RPRD1A stabilizes NRF2 and aggravates HCC progression through competing with p62 for TRIM21 binding. Cell Death & Disease 2021; 13(1) doi: 10.1038/s41419-021-04447-4
|
| 20 |
Hun Kim, Tae Hoon Roh, Jun Seop Lee, Min Seong Kim, Beom Kyung Kim. Metastatic papillary renal cell carcinoma with portal vein tumor thrombosis confirmed on blind liver biopsy. Journal of Liver Cancer 2024; 24(1): 113 doi: 10.17998/jlc.2023.11.05
|
| 21 |
Nicole Nevarez, Adam Yopp. Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Hepatocellular Carcinoma 2021; : 851 doi: 10.2147/JHC.S291530
|
| 22 |
Disha D. Shah, Bhavarth P. Dave, Parv A. Patel, Mehul R. Chorawala, Vishvas N. Patel, Palak A. Shah, Manish P. Patel. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Medical Oncology 2023; 40(2) doi: 10.1007/s12032-023-01948-4
|
| 23 |
Xiaojie Li, Zhimin Ye, Sheng Lin, Haowen Pang. Predictive factors for survival following stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumour thrombosis and construction of a nomogram. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08469-1
|
| 24 |
Abid M. Sadiq, Tendai J. Mashonganyika, Lilian G. Mmbaga, Adnan M. Sadiq, Gilbert Z. Nkya. Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombus. Clinical Case Reports 2021; 9(9) doi: 10.1002/ccr3.4800
|
| 25 |
Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?. International Journal of Radiation Biology 2022; 98(10): 1495 doi: 10.1080/09553002.2022.2055800
|
| 26 |
Dan Yang, Jiaojiao Du, Weijie Nie, Chaozhi Wang, Zhufang Ma. Combination treatment of transcatheter arterial chemoembolization, intensity-modulated radiotherapy, and sorafenib for hepatocellular carcinoma with macrovascular invasion. Medicine 2023; 102(45): e35713 doi: 10.1097/MD.0000000000035713
|
| 27 |
Sihang Cheng, Ge Hu, Zhengyu Jin, Zhiwei Wang, Huadan Xue. CT-based radiomics nomogram for prediction of survival after transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma and portal vein tumor thrombus. European Radiology 2023; 33(12): 8715 doi: 10.1007/s00330-023-09830-7
|
| 28 |
Keera Kang, Sung Kyu Song, Chul-Woon Chung, Yongkeun Park. Value of surgical resection compared to transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein tumor thrombus: A meta-analysis of hazard ratios from five observational studies. Annals of Hepato-Biliary-Pancreatic Surgery 2020; 24(3): 243 doi: 10.14701/ahbps.2020.24.3.243
|
| 29 |
Lei Zhang, Jun-Hui Sun, Zhong-Heng Hou, Bin-Yan Zhong, Min-Jie Yang, Guan-Hui Zhou, Wan-Sheng Wang, Peng Huang, Shen Zhang, Zhi Li, Xiao-Li Zhu, Zhi-Ping Yan, Cai-Fang Ni. Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study. CardioVascular and Interventional Radiology 2021; 44(1): 63 doi: 10.1007/s00270-020-02579-2
|
| 30 |
佳敏 马. Progress in the Treatment of Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus. Advances in Clinical Medicine 2021; 11(12): 6018 doi: 10.12677/ACM.2021.1112892
|
| 31 |
Yashwant Patidar, Karamvir Chandel, Naveen K. Condati, Shyam V. Srinivasan, Amar Mukund, Shiv K. Sarin. Transarterial Chemoembolization (TACE) Combined With Sorafenib versus TACE in Patients With BCLC Stage C Hepatocellular Carcinoma – A Retrospective Study. Journal of Clinical and Experimental Hepatology 2022; 12(3): 745 doi: 10.1016/j.jceh.2021.12.009
|
| 32 |
Gloria Y. Chang, Adam C. Yopp. Expanding Indications for Surgical Resection in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1): 99 doi: 10.1016/j.soc.2023.07.004
|
| 33 |
Maen Abdelrahim, Abdullah Esmail, Ala Abudayyeh, Naoka Murakami, David Victor, Sudha Kodali, Yee Lee Cheah, Caroline J. Simon, Mazen Noureddin, Ashton Connor, Ashish Saharia, Linda W. Moore, Kirk Heyne, Ahmed O. Kaseb, A. Osama Gaber, Rafik Mark Ghobrial. Transplant Oncology: An Emerging Discipline of Cancer Treatment. Cancers 2023; 15(22): 5337 doi: 10.3390/cancers15225337
|
| 34 |
Jina Kim, Hwa Kyung Byun, Tae Hyung Kim, Sun Il Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Jinsil Seong. Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Cancers 2022; 14(10): 2396 doi: 10.3390/cancers14102396
|
| 35 |
Ru Zheng, Heng-Liang Zhu, Bing-Ren Hu, Xiao-Jiao Ruan, Hua-Jie Cai. Identification of <i>APEX2</i> as an oncogene in liver cancer. World Journal of Clinical Cases 2020; 8(14): 2917-2929 doi: 10.12998/wjcc.v8.i14.2917
|
| 36 |
Yi-Hsuan Chuang, Yu-Fan Cheng, Leo Leung-Chit Tsang, Hsin-You Ou, Hsien-Wen Hsu, Wei-Xiong Lim, Po-Hsun Huang, Ching-Chun Weng, Chun-Yen Yu. Efficacy and Safety of Combined Ethanol-Lipiodol Mixture and Drug-Eluting Bead TACE for Large HCC. Journal of Hepatocellular Carcinoma 2023; : 81 doi: 10.2147/JHC.S398434
|
| 37 |
Anant Ramaswamy, Anand Kulkarni, George John, Amit Rauthan, Shekhar Patil, Ajay Duseja, Vineet Talwar, Senthil J. Rajappa, Nikhil Ghadyalpatil, Manav Wadhawan, Akash Shukla, Vamshi M. Krishna, Sujay Srinivas, Sunil Taneja, K. Mary Sravani, Sahaj Rathi, Prabhat Bhargava, Vikas Ostwal. Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP). JCO Global Oncology 2023; (9) doi: 10.1200/GO.23.00215
|
| 38 |
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinoma. Abdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
|
| 39 |
Kohei Kasahara, Takashi Kosaka, Sho Sato, Yusaku Tanaka, Hiroshi Miyamoto, Kei Sato, Atsushi Ishibe, Hirotoshi Akiyama, Chikara Kunisaki, Naoko Udaka, Satoshi Fujii, Itaru Endo. A Case of Gastrointestinal Stromal Tumor with a Tumor Embolus in the Portal Vein. The Japanese Journal of Gastroenterological Surgery 2021; 54(8): 505 doi: 10.5833/jjgs.2020.0105
|
| 40 |
Debnarayan Dutta, Sreenija Yarlagadda, Sruthi Kalavagunta, Haridas Nair, Ajay Sasidharan, Sathish Kumar Nimmya, Rajesh Kannan, Shibu George, Annex Edappattu, Nikhil K. Haridas, Wesley M. Jose, Pavithran Keechilat, Arun Valsan, Anoop Koshy, Rajesh Gopalakrishna, Shine Sadasivan, Unnikrishnan Gopalakrishnan, Dinesh Balakrishnan, Othiyil Vayoth Sudheer, Sudhindran Surendran. Co-relation of Portal Vein Tumour Thrombus Response With Survival Function Following Robotic Radiosurgery in Vascular Invasive Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2024; 14(5): 101404 doi: 10.1016/j.jceh.2024.101404
|
| 41 |
Neris Dincer, Gamze Ugurluer, Teuta Zoto Mustafayev, Gorkem Gungor, Banu Atalar, Koray Guven, Enis Ozyar. Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium. Cureus 2022; doi: 10.7759/cureus.23981
|
| 42 |
Munire Abulimiti, Zhenyu Li, Haifeng Wang, Palida Apiziaji, Yisikandaer Abulimiti, Yao Tan, Pierfrancesco Franco. Combination Intensity-Modulated Radiotherapy and Sorafenib Improves Outcomes in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9943683
|
| 43 |
Sandeep Arora, Carla Harmath, Roberta Catania, Ari Mandler, Kathryn J. Fowler, Amir A. Borhani. Hepatocellular carcinoma: metastatic pathways and extra-hepatic findings. Abdominal Radiology 2021; 46(8): 3698 doi: 10.1007/s00261-021-03151-3
|
| 44 |
Zhiqing Mo, Hao Ding, Xiaojiao Zhou, Zisan Zeng, Liling Long. Gd-EOB-DTPA-enhanced magnetic resonance imaging may help identify patients with hepatocellular carcinoma eligible for treatment targeted at RAF1. Abdominal Radiology 2022; 47(1): 209 doi: 10.1007/s00261-021-03325-z
|
| 45 |
Roberta Catania, Kalina Chupetlovska, Amir A. Borhani, Ekta Maheshwari, Alessandro Furlan. Tumor in vein (LR-TIV) and liver imaging reporting and data system (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications. Abdominal Radiology 2021; 46(12): 5723 doi: 10.1007/s00261-021-03270-x
|
| 46 |
Ya-Lin Kong, Jin-Jin Sun, Hong-Yi Zhang, Ying Xing, Cheng Wang, Yang Liu, Xiao-Jun He, Ling-Hong Kong, Cheng-Li Liu. Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patients. Surgical Endoscopy 2023; 37(2): 1173 doi: 10.1007/s00464-022-09639-3
|
| 47 |
Muhammad Nabeel Shafqat, Najam us Sehar Saeed, Salman Javed, Muhammad Adil Chouhdary, Ghania Shafqat, Muhammad Asad Aftab. Frequency of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma. Pakistan Journal of Health Sciences 2022; : 115 doi: 10.54393/pjhs.v3i05.219
|
| 48 |
P. G. Tarazov. Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma. Review of the Literature. Journal of oncology: diagnostic radiology and radiotherapy 2023; 6(4): 62 doi: 10.37174/2587-7593-2023-6-4-62-67
|
| 49 |
Shin Hwang, Deok-Bog Moon, Ki-Hun Kim, Chul-Soo Ahn, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Sung-Gyu Lee. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis. Journal of Gastrointestinal Surgery 2021; 25(7): 1745 doi: 10.1007/s11605-020-04800-6
|
| 50 |
Ting Ye, Shi-Han Shao, Kan Ji, Shu-Lin Yao. Evaluation of short-term effects of drug-loaded microspheres and traditional transcatheter arterial chemoembolization in the treatment of advanced liver cancer. World Journal of Gastrointestinal Oncology 2022; 14(12): 2367-2379 doi: 10.4251/wjgo.v14.i12.2367
|
| 51 |
So Hyun Park, Bohyun Kim, Sehee Kim, Suyoung Park, Yeon Ho Park, Seung Kak Shin, Pil Soo Sung, Joon-Il Choi. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid–enhanced MRI: risk scoring system development and validation. European Radiology 2023; 33(5): 3566 doi: 10.1007/s00330-023-09539-7
|
| 52 |
Dae Yang, Sunmin Park, Chai Rim, Won Yoon, In-Soo Shin, Han Lee. Salvage External Beam Radiotherapy after Incomplete Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review. Medicina 2021; 57(10): 1000 doi: 10.3390/medicina57101000
|
| 53 |
Debnarayan Dutta, Tushar Tatineni, Sreenija Yarlagadda, Ajinkya Gupte, Sruthi K. Reddy, Ram Madhavan, Haridas Nair, Ajay Sasidharan, Rajesh Kannan, Shibu G. Pottayil, Raghavendra Holla, Surendran Sudhindran. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study. Indian Journal of Gastroenterology 2021; 40(4): 389 doi: 10.1007/s12664-021-01172-w
|
| 54 |
Role of rapid arc-image-guided radiotherapy in hepatocellular carcinoma with portal vein tumor thrombosis: A study from tertiary care center in Punjab, India. Journal of Cancer Research and Therapeutics 2023; 19(3): 639 doi: 10.4103/jcrt.jcrt_365_21
|
| 55 |
Yanyan Cao, Tao Sun, Xiaopeng Guo, Tao Ouyang, Xuefeng Kan, Lei Chen, Bin Liang, Mingfu Wang, Chuansheng Zheng. Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.673378
|
| 56 |
Young Chang, Su Jong Yu, Hyo-Cheol Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jin Wook Chung, Jung-Hwan Yoon. Reappraisal of Portal Vein Tumor Thrombosis as a Prognostic Factor for Patients with Hepatocellular Carcinoma. Gut and Liver 2024; 18(1): 156 doi: 10.5009/gnl230057
|
| 57 |
Akash Shukla, Shraddha Patkar, Sridhar Sundaram, Samir R. Shah, Meghraj Ingle, Amit Gupta, Amrit Gopan, Mrunal Kamat, Ravi Mohanka, Sandeep Singh, Swapnil Walke, Vikas Pandey, Mahesh Goel. Clinical Profile, Patterns of Care & adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study. Journal of Clinical and Experimental Hepatology 2022; 12(6): 1463 doi: 10.1016/j.jceh.2022.05.006
|
| 58 |
Guangxin Li, Bin Shu, Zhuozhao Zheng, Hongfang Yin, Chen Zhang, Ying Xiao, Yanmei Yang, Zhe Yan, Xiaofei Zhang, Shizhong Yang, Gong Li, Jiahong Dong. Safety and efficacy of radiotherapy combined with lenvatinib plus PD-1 inhibitors as neo-adjuvant therapy in hepatocellular carcinoma with portal vein thrombus: protocol of an open-label, single-arm, prospective, multi-center phase I trial. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1051916
|
| 59 |
Ahmed Shehta, Ahmed Farouk, Ahmed Nabieh Elghawalby, Mohamed Elshobary, Ahmed Aboelenin, Amgad Fouad, Mahmoud Abdelwahab Ali. Outcomes of Hepatic Resection for Hepatocellular Carcinoma Associated with Portal Vein Invasion. Journal of Surgical Research 2021; 266: 269 doi: 10.1016/j.jss.2021.04.011
|
| 60 |
Kathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, Georgios Tsoulfas. Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advances. World Journal of Clinical Oncology 2022; 13(6): 448-472 doi: 10.5306/wjco.v13.i6.448
|
| 61 |
Long-Wang Lin, Le-Ye Yan, Kun Ke, Wei-Zhu Yang, Jun-Qing Lin, Ning Huang. Efficacy and safety of transarterial chemoembolization combined with lenvatinib, programmed death-1 inhibitor, and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Brachytherapy 2023; 22(6): 858 doi: 10.1016/j.brachy.2023.06.229
|
| 62 |
Arndt Vogel, Richard S. Finn, Marie-Hélène Blanchet Zumofen, Carolina Heuser, Javier Sanchez Alvarez, Michael Leibfried, Catherine R. Mitchell, Sarah Batson, Gabrielle Redhead, Vincent E. Gaillard, Masatoshi Kudo. Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis. Liver Cancer 2023; 12(6): 510 doi: 10.1159/000533166
|
| 63 |
So Jung Lee, Myungsoo Kim, Yoo-Kang Kwak, Hye Jin Kang. MRI-guided radiotherapy for PVTT in HCC patients: evaluation of the efficacy and safety. Journal of Cancer Research and Clinical Oncology 2022; 148(9): 2405 doi: 10.1007/s00432-021-03788-z
|
| 64 |
Zi-Wen Tao, Bao-Quan Cheng, Tao Zhou, Yan-Jing Gao. Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 134 doi: 10.1016/j.hbpd.2021.12.004
|
| 65 |
Zhao Wu, Lifeng Cui, Junlin Qian, Laihui Luo, Shuju Tu, Fei Cheng, Lebin Yuan, WenJian Zhang, Wei Lin, Hongtao Tang, Xiaodong Li, Hui Li, Yang Zhang, Jisheng Zhu, Yong Li, Yuanpeng Xiong, Zemin Hu, Peng Peng, Yongzhu He, Liping Liu, Kun He, Wei Shen. Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10802-9
|
| 66 |
Alexander E. Hare, Mina S. Makary. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 307 doi: 10.1007/16833_2022_42
|
| 67 |
Matteo Renzulli, Francesco Tovoli, Alfredo Clemente, Anna Maria Ierardi, Irene Pettinari, Giuliano Peta, Giovanni Marasco, Davide Festi, Fabio Piscaglia, Salvatore Cappabianca, Gianpaolo Carrafiello, Rita Golfieri. Ablation for hepatocellular carcinoma: beyond the standard indications. Medical Oncology 2020; 37(4) doi: 10.1007/s12032-020-01348-y
|
| 68 |
Seyda Gunduz, Gia Saini, Nicole Segaran, Sailen Naidu, Indravadan Patel, Sadeer Alzubaidi, Rahmi Oklu. Radioembolization for Hepatocellular Carcinoma. Digestive Disease Interventions 2021; 5(03): 268 doi: 10.1055/s-0041-1732304
|
| 69 |
Lucia Cerrito, Maria Elena Ainora, Silvino Di Francesco, Linda Galasso, Antonio Gasbarrini, Maria Assunta Zocco. The Role of Contrast-Enhanced Ultrasound (CEUS) in the Detection of Neoplastic Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma. Tomography 2023; 9(5): 1976 doi: 10.3390/tomography9050154
|
| 70 |
Manuel Lim, Jongman Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh. Liver resection in selective hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombosis improves prognosis. Journal of Liver Cancer 2024; 24(1): 102 doi: 10.17998/jlc.2024.01.31
|
| 71 |
Seungji Lee, Sung Kyu Song, Byungje Bae, Yongkeun Park. Comparing efficacies of different treatment regimens in patients with hepatocellular carcinoma accompanied by portal vein tumor thrombus using network meta-analysis. Annals of Surgical Treatment and Research 2022; 103(5): 280 doi: 10.4174/astr.2022.103.5.280
|
| 72 |
Alexander Villalobos, Mohamed M. Soliman, Bill S. Majdalany, David M. Schuster, James Galt, Zachary L. Bercu, Nima Kokabi. Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. Seminars in Interventional Radiology 2020; 37(05): 543 doi: 10.1055/s-0040-1720954
|
| 73 |
Fabrizia Gelardi, Marcello Rodari, Cristiano Pini, Roberta Zanca, Alessia Artesani, Giovanni Tosi, Arturo Chiti, Martina Sollini. ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization. Frontiers in Nuclear Medicine 2022; 2 doi: 10.3389/fnume.2022.934446
|
| 74 |
Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Akinori Kubo, Yoshimasa Tokuchi, Takashi Kitagataya, Osamu Maehara, Shunsuke Ohnishi, Taku Shigesawa, Akihisa Nakamura, Ren Yamada, Masatsugu Ohara, Naoki Kawagishi, Mitsuteru Natsuizaka, Masato Nakai, Kenichi Morikawa, Ken Furuya, Masaru Baba, Yoshiya Yamamoto, Kazuharu Suzuki, Takaaki Izumi, Takashi Meguro, Katsumi Terashita, Jun Ito, Takuto Miyagishima, Naoya Sakamoto. Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria. Hepatology Research 2021; 51(9): 979 doi: 10.1111/hepr.13693
|
| 75 |
Sang Jin Kim, Jong Man Kim. Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis. Journal of Liver Cancer 2021; 21(2): 105 doi: 10.17998/jlc.2021.03.17
|
| 76 |
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen. Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen. Journal for ImmunoTherapy of Cancer 2023; 11(4): e006334 doi: 10.1136/jitc-2022-006334
|